In polycythemia vera and other myeloproliferative neoplasms, PP2A’s tumor-suppressive function is inhibited by phosphorylated SET, a process mediated through JAK-STAT and PI3K-PKC signaling [113]. Here, PTPA is linked to neoplasm.